Healthcare provider profile · identity verified

Malrubio Cabrera, MD

Internal Medicine · SACRAMENTO, CA · NPI 1871671537

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	591	216
Lisinopril	Lisinopril	348	127
Amlodipine Besylate	Amlodipine Besylate	334	137
Levothyroxine Sodium	Levothyroxine Sodium	246	79
Losartan Potassium	Losartan Potassium	185	73
Metoprolol Tartrate	Metoprolol Tartrate	170	64
Hydrochlorothiazide	Hydrochlorothiazide	166	67
Tamsulosin Hcl	Tamsulosin Hcl	140	55
Simvastatin	Simvastatin	118	39
Metformin Hcl	Metformin Hcl	117	46
Fluticasone Propionate	Fluticasone Propionate	107	40
Furosemide	Furosemide	92	33
Ibuprofen	Ibuprofen	90	34
Albuterol Sulfate Hfa	Albuterol Sulfate	76	48
Famotidine	Famotidine	76	33
Gabapentin	Gabapentin	76	31
Terazosin Hcl	Terazosin Hcl	74	22
Pantoprazole Sodium	Pantoprazole Sodium	73	32
Atenolol	Atenolol	71	26
Metformin Hcl Er	Metformin Hcl	63	25
Glipizide	Glipizide	62	28
Omeprazole	Omeprazole	58	23
Humulin N	Insulin Nph Human Isophane	57	23
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	55	55
Metoprolol Succinate	Metoprolol Succinate	48	18
Alendronate Sodium	Alendronate Sodium	45	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	21
Alvesco	Ciclesonide	44	14
Fluoxetine Hcl	Fluoxetine Hcl	43	20
Allopurinol	Allopurinol	42	19
Trazodone Hcl	Trazodone Hcl	41	14
Hydralazine Hcl	Hydralazine Hcl	37	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	19
Lovastatin	Lovastatin	36	12
Humulin R	Insulin Regular, Human	35	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	11
Clopidogrel	Clopidogrel Bisulfate	33	16
Clonidine Hcl	Clonidine Hcl	28	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	28	suppressed
Carvedilol	Carvedilol	27	12
Colchicine	Colchicine	26	suppressed
Finasteride	Finasteride	26	suppressed
Sertraline Hcl	Sertraline Hcl	25	11
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	25	12
Prednisone	Prednisone	23	17
Eliquis	Apixaban	22	suppressed
Lactulose	Lactulose	22	suppressed
Naproxen	Naproxen	21	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Nabumetone	Nabumetone	19	13
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	15	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error